Literature DB >> 20658140

[Pregnancy and inflammatory rheumatic diseases].

R Fischer-Betz1, E Gromnica-Ihle.   

Abstract

Inflammatory rheumatic diseases often affect females of childbearing age and pregnancy remains a challenge for this group of patients and their physicians. However, the majority of patients can now have successful pregnancies and deliver healthy babies as a result of our improved knowledge of the risks encountered during pregnancy, better preventive and therapeutic measures, and in particular close rheumatological, obstetric and neonatal monitoring. To ensure a favorable outcome, pregnancy should be planned to take place during a period of disease stability, monitored closely (physical examination, laboratory tests, and Doppler ultrasound), and treated appropriately.

Entities:  

Mesh:

Year:  2010        PMID: 20658140     DOI: 10.1007/s00393-010-0661-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  21 in total

Review 1.  [Drug therapy during pregnancy and breast feeding. Updated summary].

Authors:  K Krüger; E Gromnica-Ihle
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

2.  Women with inflammatory polyarthritis have babies of lower birth weight.

Authors:  A P Bowden; J H Barrett; W Fallow; A J Silman
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

3.  Pregnancy outcomes in women with rheumatoid arthritis in Washington State.

Authors:  Susan D Reed; Teresa A Vollan; Megan A Svec
Journal:  Matern Child Health J       Date:  2006-07

4.  Ankylosing spondylitis--the female aspect.

Authors:  M Ostensen; H Ostensen
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

5.  Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus.

Authors:  Eliza F Chakravarty; Iris Colón; Elizabeth S Langen; David A Nix; Yasser Y El-Sayed; Mark C Genovese; Maurice L Druzin
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

Review 6.  [Pregnancy in patients with rheumatoid arthritis and inflammatory spondylarthropathies].

Authors:  E Gromnica-Ihle; M Ostensen
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

Review 7.  Neonatal lupus syndromes.

Authors:  Peter M Izmirly; Tania L Rivera; Jill P Buyon
Journal:  Rheum Dis Clin North Am       Date:  2007-05       Impact factor: 2.670

8.  A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Authors:  John D Carter; Anil Ladhani; Louis R Ricca; Joanne Valeriano; Frank B Vasey
Journal:  J Rheumatol       Date:  2009-03       Impact factor: 4.666

9.  A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments.

Authors:  M Østensen; L Fuhrer; R Mathieu; M Seitz; P M Villiger
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

10.  EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Authors:  G Bertsias; J P A Ioannidis; J Boletis; S Bombardieri; R Cervera; C Dostal; J Font; I M Gilboe; F Houssiau; T Huizinga; D Isenberg; C G M Kallenberg; M Khamashta; J C Piette; M Schneider; J Smolen; G Sturfelt; A Tincani; R van Vollenhoven; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2007-05-15       Impact factor: 19.103

View more
  3 in total

1.  [Rheumatic diseases during pregnancy].

Authors:  R Fischer-Betz
Journal:  Internist (Berl)       Date:  2012-09       Impact factor: 0.743

2.  Core set of recommendations for patients with ankylosing spondylitis concerning behaviour and environmental adaptations.

Authors:  Ernst Feldtkeller; Gudrun Lind-Albrecht; Martin Rudwaleit
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

3.  [Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].

Authors:  M Aringer; R Fischer-Betz; F Hiepe
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.